Evidence map›Paper›PMID 35435032›Full record

Observational studyThe journal of vascular access2023

Closed intravenous systems for central vascular access: A difference maker for CLABSI rates in neonates?

Matheus F P T van Rens, Kevin Hugill, Airene L V Francia, Mohamad Adnan Mahmah, Afaf Boulous J Al Shadad, Imelda Caseres Chiuco, Krisha L P Garcia

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in The journal of vascular access, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Reducing umbilical catheter migration rates by using a novel securement device.Journal of perinatology : official journal of the California Perinatal Association · 2024
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Matheus F P T van RensDirector of Nursing and Neonatal Vascular Access Lead, Neonatal Intensive Care Unit, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.ORCID 0000-0002-9595-0265
Kevin HugillDirector of Nursing Education, Hamad Medical Corporation, Doha, Qatar.
Airene L V FranciaVascular Access and Neonatal Transport Team Coordinator, Neonatal Intensive Care Unit, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.
Mohamad Adnan MahmahSenior Consultant Critical Care, QI lead, Neonatal Intensive Care Unit, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.
Afaf Boulous J Al ShadadSenior Consultant Critical Care, Infection Control Lead, Neonatal Intensive Care Unit, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.
Imelda Caseres ChiucoInfection Control Practitioner, Women's Wellness and Research Center, Doha, Qatar.
Krisha L P GarciaNurse Educator, Neonatal Intensive Care Unit, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.
Hamad Medical Corporation · QAQatar Airways (Qatar) · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInfants in neonatal units are susceptible to numerous potential iatrogenic risks. One key concern is central line-associated blood stream infection (CLABSI). To ensure patient safety and reduce the incidence of CLABSI toward zero, numerous evidence-based clinical interventions and product innovations have been implemented. Nevertheless, sustaining zero CLABSI for sustained periods remains challenging.

aimThe purpose of this study was to evaluate the impact on CLABSI rates of introducing a preassembled closed intravenous (IV) administration set in a neonatal intensive care unit (NICU).

methodsThis was a retrospective observational analysis of routinely collected anonymized IV therapy infection data in a NICU. The study period was from January 2019 through June 2020.

resultsNine-hundred eighty five patients with a Epicutaneo-Caval Catheter (ECC) were included (456 legacy IV set, 529 closed IV set). Patient demographics were comparable between the two groups. ECC dwell time was the only IV characteristic associated (

conclusionsUtilization of a pre-assembled closed IV administration set was associated with a reduction in CLABSI rates. The study results suggest that using a pre-assembled closed IV set concurrently with evidence-based central line infection control interventions can help attain extended periods of zero CLABSI.

Indexed as

Catheterization, Central VenousCatheter-Related InfectionsCentral Venous CathetersHumansInfantInfant, NewbornInfection ControlIntensive Care Units, NeonatalCentral line-associated blood stream infectionCLABSIEpicutaneo-Caval Catheter (ECC)Luer activated valveNeedle-free connectorNeonateNICU

Identifiers

PMID35435032
PMCPMC10714695
OpenAlexW4223991919

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.